Motif ID | Motif Logo | Scanned Score Distribution | Frequency of Motif | Replicability Score | Evolutionary Conservation Score | Gene Targets | Gene Ontology of CpGMM targets |
---|---|---|---|---|---|---|---|
CG_h1r2_promoter_n_RM_12_19_1 | ![]() |
![]() |
3 | 0.5 | 8.01E-04 | BCL2, NUMBL | negative regulation of cellular pH reduction [BP], CD8-positive, alpha-beta T cell lineage commitment [BP], positive regulation of neuron maturation [BP], neuroblast division in subventricular zone [BP], negative regulation of mitochondrial depolarization [BP], positive regulation of skeletal muscle fiber development [BP], negative regulation of retinal cell programmed cell death [BP], cochlear nucleus development [BP] |
CG_h1r2_promoter_n_RM_12_12_2 | ![]() |
![]() |
3 | 0.75 | 3.30E-04 | RBMX, CWC15 | catalytic step 2 spliceosome [CC] |
CG_h1r2_promoter_n_RM_14_9_1 | ![]() |
![]() |
1 | 0.25 | 3.92E-05 | IRS2 | negative regulation of plasma membrane long-chain fatty acid transport [BP] |
CG_h1r2_promoter_n_RM_12_1_3 | ![]() |
![]() |
1 | 0.25 | 5.05E-05 | MAGI2, CD63 | regulation of rubidium ion transport [BP], beta-1 adrenergic receptor binding [MF], type II activin receptor binding [MF] |
CG_h1r2_promoter_n_RM_12_11_3 | ![]() |
![]() |
3 | 0.75 | 5.42E-05 | EDNRB, LDB1, ITGA5, NFS1 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery [BP], enteric smooth muscle cell differentiation [BP], endothelin receptor signaling pathway [BP], leukocyte migration [BP], histone H3-K4 acetylation [BP], cysteine desulfurase activity [MF] |
CG_h1r2_promoter_n_RM_12_9_2 | ![]() |
![]() |
1 | 0.25 | 2.04E-04 | PEX5L | peroxisome matrix targeting signal-1 binding [MF] |
CG_h1r2_promoter_n_RM_12_8_2 | ![]() |
![]() |
1 | 0.25 | 1.29E-04 | SCARB1 | high-density lipoprotein particle receptor activity [MF] |
CG_h1r2_promoter_n_RM_12_13_2 | ![]() |
![]() |
1 | 0.25 | 5.84E-05 | ADAM8, YES1, TJP1 | cell-cell signaling involved in cell-cell junction organization [BP], positive regulation of neutrophil extravasation [BP], regulation of vascular permeability [BP], positive regulation of fibronectin-dependent thymocyte migration [BP], dense core granule membrane [CC], alpha9-beta1 integrin-ADAM8 complex [CC], positive regulation of eosinophil migration [BP] |
CG_h1r2_promoter_n_RM_12_4_2 | ![]() |
![]() |
1 | 0.25 | 6.78E-05 | RECQL, MRE11A | DNA duplex unwinding [BP], ATP-dependent DNA helicase activity [MF], DNA helicase activity [MF] |
CG_h1r2_promoter_n_RM_12_18_2 | ![]() |
![]() |
3 | 0.5 | 2.56E-04 | ACD, MGAT1 | positive regulation of single-stranded telomeric DNA binding [BP], alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity [MF], UDP-N-acetylglucosamine catabolic process [BP] |
CG_h1r2_promoter_n_RM_14_5_3 | ![]() |
![]() |
6 | 1.0 | 1.54E-04 | PIF1, CCNL2, CD2BP2, PRPF8 | nuclear speck [CC], U5 snRNP [CC], ATP-dependent 5'-3' DNA/RNA helicase activity [MF] |
CG_h1r2_promoter_n_RM_12_20_2 | ![]() |
![]() |
2 | 0.5 | 2.43E-04 | CSNK1E, CLU, PLXNA2 | cerebellar granule cell precursor tangential migration [BP], positive regulation of proteasomal ubiquitin-dependent protein catabolic process [BP] |
CG_h1r2_promoter_n_RM_12_2_1 | ![]() |
![]() |
3 | 0.75 | 4.21E-05 | ITGA5 | alphav-beta3 integrin-vitronectin complex [CC] |
CG_h1r2_promoter_n_RM_14_4_2 | ![]() |
![]() |
7 | 1.0 | 2.26E-04 | SHANK1, MGEA5 | habituation [BP], somatostatin receptor binding [MF], determination of affect [BP], negative regulation of cardiac muscle adaptation [BP] |
CG_h1r2_promoter_n_RM_12_21_1 | ![]() |
![]() |
2 | 0.5 | 3.99E-04 | SLC6A9, BACE1, NODAL | left lung morphogenesis [BP], positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry [BP], negative regulation of chorionic trophoblast cell proliferation [BP], epiblast cell-extraembryonic ectoderm cell signaling involved in anterior/posterior axis specification [BP], axial mesodermal cell fate specification [BP], transforming growth factor beta receptor signaling pathway involved in primitive streak formation [BP], glycine:sodium symporter activity [MF], beta-aspartyl-peptidase activity [MF], type I activin receptor binding [MF], polarity specification of proximal/distal axis [BP], inhibition of neuroepithelial cell differentiation [BP] |
CG_h1r2_promoter_n_RM_12_24_2 | ![]() |
![]() |
2 | 0.5 | 4.22E-05 | GNPDA1, DNPH1 | nucleoside deoxyribosyltransferase activity [MF], glucosamine catabolic process [BP], deoxyribonucleoside 5'-monophosphate N-glycosidase activity [MF] |
CG_h1r2_promoter_n_RM_12_16_2 | ![]() |
![]() |
4 | 1.0 | 2.53E-04 | COL2A1, CELF4 | BRE binding [MF], collagen type II [CC] |
CG_h1r2_promoter_n_RM_14_1_2 | ![]() |
![]() |
4 | 0.75 | 5.68E-04 | PSMD12 | viral reproduction [BP] |
CG_h1r2_promoter_n_RM_12_6_1 | ![]() |
![]() |
1 | 0.25 | 3.09E-04 | AARS2, NUDT12 | NADP catabolic process [BP], NAD catabolic process [BP], mitochondrial alanyl-tRNA aminoacylation [BP], NAD+ diphosphatase activity [MF] |
CG_h1r2_promoter_n_RM_12_17_3 | ![]() |
![]() |
3 | 0.75 | 2.71E-04 | CELF4, COL2A1, CACNG2 | BRE binding [MF], membrane depolarization [BP], collagen type II [CC] |
CG_h1r2_promoter_n_RM_12_14_2 | ![]() |
![]() |
4 | 1.0 | 6.92E-05 | ANGPT2 | negative regulation of cell-substrate adhesion [BP], negative regulation of positive chemotaxis [BP] |
CG_h1r2_promoter_n_RM_12_23_1 | ![]() |
![]() |
3 | 0.75 | 1.96E-04 | PAF1, RIPK3 | mitochondrion [CC] |
CG_h1r2_promoter_n_RM_14_3_1 | ![]() |
![]() |
2 | 0.5 | 1.88E-05 | OCA2, SCRIB | arsenite transmembrane transporter activity [MF], protein localization to adherens junction [BP], synaptic vesicle targeting [BP], tyrosine transport [BP], L-tyrosine transmembrane transporter activity [MF], arsenite transport [BP], Scrib-APC-beta-catenin complex [CC] |
CG_h1r2_promoter_n_RM_12_22_1 | ![]() |
![]() |
4 | 0.75 | 2.45E-04 | DACT2 | negative regulation of nodal signaling pathway [BP], inner medullary collecting duct development [BP] |
CG_h1r2_promoter_n_RM_12_15_2 | ![]() |
![]() |
4 | 0.75 | 2.28E-04 | IRX2 | proximal/distal pattern formation involved in metanephric nephron development [BP] |
CG_h1r2_promoter_n_RM_14_2_1 | ![]() |
![]() |
3 | 0.5 | 1.60E-04 | SLC22A17 | siderophore transport [BP] |